drugset / Trial / NCT00518466
Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to describe the single- and multiple-dose pharmacokinetic profiles of two novel formulations of topiramate and commercially available immediate release topiramate, all dosed with immediate release phentermine.
Timeline
- Start
- 2007-07
- Primary completion
- 2007-09
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phentermine | Small molecule | 7.5 mg | — |
| Subject | Phentermine | Small molecule | 37.5 mg | — |
| Subject | Topiramate | Small molecule | 25 mg | — |
| Subject | Topiramate | Small molecule | 100 mg | — |